Spruce Biosciences SPRB
NASDAQ SPRB
$45.71 +0.94 (+2.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

Spruce Biosciences (SPRB) Selling, General & Administrative (2019 - 2026)

Updated

Spruce Biosciences' Selling, General & Administrative was $4.35 million in Q2 2026, up 39.3% from $3.12 million a year earlier but down 1.4% from the prior quarter.

Analysis

Spruce Biosciences (SPRB) Selling, General & Administrative (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Spruce Biosciences' Selling, General & Administrative was $18.98 million through Jun 30, 2026, up 40.1% year-over-year; for FY2025, it was $16.99 million, up 16.0% from FY2024.

  • Selling, General & Administrative has now increased for six consecutive years, with a five-year compound annual growth rate of 25.0% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $14.64 million in FY2024 (+15.8%), $12.65 million in FY2023 (+4.7%), $12.09 million in FY2022 (+6.3%) and $11.37 million in FY2021 (+104.4%).
  • Quarterly Selling, General & Administrative has moved between $2.77 million (Q3 2022) and $7 million (Q4 2025) over five years.
  • Compared with a year earlier, Selling, General & Administrative has increased for three straight quarters, with growth averaging 19.5% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2025 (growth of 111.1%); the worst was Q1 2025 (a decline of 15.4%).
  • Per Business Quant data, SPRB's Selling, General & Administrative in the three quarters before Q2 2026 was $4.41 million (Q1 2026), $7 million (Q4 2025) and $3.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Spruce Biosciences 123.24 Mn 123.24 Mn - 4.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.35 Mn
Mar 31, 2026 4.41 Mn
Dec 31, 2025 7.00 Mn
Sep 30, 2025 3.22 Mn
Jun 30, 2025 3.12 Mn
Mar 31, 2025 3.66 Mn
Dec 31, 2024 3.31 Mn
Sep 30, 2024 3.46 Mn
Jun 30, 2024 3.56 Mn
Mar 31, 2024 4.32 Mn
Dec 31, 2023 2.95 Mn
Sep 30, 2023 3.24 Mn
Jun 30, 2023 3.01 Mn
Mar 31, 2023 3.45 Mn
Dec 31, 2022 3.27 Mn
Sep 30, 2022 2.77 Mn
Jun 30, 2022 2.82 Mn
Mar 31, 2022 3.23 Mn
Dec 31, 2021 2.88 Mn
Sep 30, 2021 2.79 Mn
API Access

Spruce Biosciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SPRB&period=max&api_key=YOUR_API_KEY